stars 1 stars 2 stars 3

Predictive Therapeutics, a Precision Medicine drug development company, has raised over $2,500,00.00 in Series A funding. Dr. Marcel Rozencweig has joined Predictive Therapeutics as the Chief Medical Officer, Ramona Lloyd Phd. has joined as Chief Regulatory Officer and Nobel prize winner Dr. Roger Kornberg has joined as Chief Scientist. Biotech entrepreneur CEO, Dr. Asher Nathan, stated "I am extremely proud of the high quality senior management team we have been able to attract, and the faith that our Series A investors have placed in our ability to succeed. We are extremely excited by the steps we have been able to accomplish early in our existence."

Predictive Therapeutics Questions

The Predictive Therapeutics annual revenue was $5.4 million in 2026.

Predictive Therapeutics is based in Rehovot, Central District.

The NAICS codes for Predictive Therapeutics are [54, 5417, 541, 541714, 54171].

The SIC codes for Predictive Therapeutics are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users